Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Aclara, Caliper Technologies Corp. enabling technology news

CALP said that it added U.S. Patent No. 6,033,546, covering microfluidic

Read the full 117 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE